Equity Profile

RGC

Regencell Bioscience Holdings Limited

Health CarePharmaceuticals$2.6B

Jun27Thu

Pre-Earnings Brief

UpcomingQ4-2017After Close5:00 PM EDT

Company Snapshot

Regencell Bioscience Holdings Limited operates in the health care sector, focusing on pharmaceuticals. The company is involved in developing innovative treatments, which is crucial as the demand for effective medical solutions continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help investors gauge financial health this quarter.

$0.11

Revenue Growth

Understanding revenue trends is essential for assessing the company's market performance and future potential.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RGC Q4-2017 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-3.97%

Avg Stock Reaction

+0.00%

Last Quarter Recap

In the last quarter, Regencell reported an EPS of $0.07, which was below the expected $0.11, resulting in a negative surprise. The stock's performance following the report was subdued, reflecting investor concerns.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Regencell's upcoming earnings are cautious, especially given the recent earnings misses. Investors are looking for signs of improvement in profitability and revenue.

Bull Case

If Regencell can exceed EPS expectations and show signs of revenue growth, it could signal a turnaround, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could further erode investor trust and lead to a decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.11

EPS is a key indicator of a company's profitability and will help investors gauge financial health this quarter.

Revenue Growth

N/A

Understanding revenue trends is essential for assessing the company's market performance and future potential.

Market Reaction

N/A

The immediate market reaction post-earnings can provide insights into investor sentiment and confidence in the company's future.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the expected $0.11?

Meeting or exceeding EPS expectations is crucial for restoring investor confidence after previous misses.

What is the outlook for revenue growth?

Clear guidance on revenue growth will be vital for assessing the company's future prospects and overall market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly cautious given Regencell's recent performance, potentially underestimating the company's ability to rebound this quarter.

Supporting Evidence

The options market is pricing in an 11.9% move, suggesting expectations for volatility that could favor a positive surprise.

Historical patterns show that stocks can rebound sharply after a series of misses, indicating potential for a turnaround.

Key Risk

If EPS comes in above $0.11, it could shift the narrative and restore confidence in the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a series of earnings misses, and investors are looking for signs of recovery.

Bull Confirmed If

Achieving an EPS of $0.11 or better would confirm a positive turnaround in profitability.

Bear Confirmed If

An EPS below $0.07 would reinforce concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±11.9%

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings report.

Detail

ATM IV

1.4%

30d HV

69.6%

Calls (5K)P/C Ratio: 0.02Puts (7K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Regencell beats expectations, history suggests the stock could rise significantly, confirming a positive shift in performance.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors weigh the company's future potential against past performance.

Miss

If the company misses again, the average historical move suggests a potential decline in stock price, further impacting investor sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or clinical trials.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Guidance on future revenue expectations and growth strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun25

SNXReported

TD SYNNEX Corporation

RecapView

Jun25

CUKReported

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help investors gauge financial health this quarter.

$0.11

Revenue Growth

Understanding revenue trends is essential for assessing the company's market performance and future potential.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

RGC Q4-2017 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-3.97%

Avg Stock Reaction

+0.00%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Regencell's upcoming earnings are cautious, especially given the recent earnings misses. Investors are looking for signs of improvement in profitability and revenue.

Bull Case

If Regencell can exceed EPS expectations and show signs of revenue growth, it could signal a turnaround, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could further erode investor trust and lead to a decline in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.11

EPS is a key indicator of a company's profitability and will help investors gauge financial health this quarter.

Revenue Growth

N/A

Understanding revenue trends is essential for assessing the company's market performance and future potential.

Market Reaction

N/A

The immediate market reaction post-earnings can provide insights into investor sentiment and confidence in the company's future.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the expected $0.11?

Meeting or exceeding EPS expectations is crucial for restoring investor confidence after previous misses.

What is the outlook for revenue growth?

Clear guidance on revenue growth will be vital for assessing the company's future prospects and overall market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly cautious given Regencell's recent performance, potentially underestimating the company's ability to rebound this quarter.

Supporting Evidence

The options market is pricing in an 11.9% move, suggesting expectations for volatility that could favor a positive surprise.

Historical patterns show that stocks can rebound sharply after a series of misses, indicating potential for a turnaround.

Key Risk

If EPS comes in above $0.11, it could shift the narrative and restore confidence in the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a series of earnings misses, and investors are looking for signs of recovery.

Bull Confirmed If

Achieving an EPS of $0.11 or better would confirm a positive turnaround in profitability.

Bear Confirmed If

An EPS below $0.07 would reinforce concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±11.9%

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings report.

Detail

ATM IV

1.4%

30d HV

69.6%

Calls (5K)P/C Ratio: 0.02Puts (7K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Regencell beats expectations, history suggests the stock could rise significantly, confirming a positive shift in performance.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors weigh the company's future potential against past performance.

Miss

If the company misses again, the average historical move suggests a potential decline in stock price, further impacting investor sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product developments or clinical trials.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management and operational efficiencies.
4Guidance on future revenue expectations and growth strategies.